Growth Metrics

RxSight (RXST) Return on Capital Employed (2021 - 2025)

RxSight (RXST) has disclosed Return on Capital Employed for 5 consecutive years, with 0.03% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Capital Employed fell 1.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Dec 2025, down 1.0%, and an annual FY2025 reading of 0.03%, changed 0.0% over the prior year.
  • Return on Capital Employed was 0.03% for Q4 2025 at RxSight, up from 0.05% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.02% in Q1 2025 and bottomed at 0.47% in Q4 2022.
  • Average Return on Capital Employed over 5 years is 0.24%, with a median of 0.3% recorded in 2023.
  • The sharpest move saw Return on Capital Employed decreased -18bps in 2022, then increased 29bps in 2024.
  • Year by year, Return on Capital Employed stood at 0.28% in 2021, then plummeted by -65bps to 0.47% in 2022, then surged by 33bps to 0.31% in 2023, then skyrocketed by 94bps to 0.02% in 2024, then plummeted by -44bps to 0.03% in 2025.
  • Business Quant data shows Return on Capital Employed for RXST at 0.03% in Q4 2025, 0.05% in Q3 2025, and 0.04% in Q2 2025.